Skip to main content
Top
Published in: Clinical Rheumatology 6/2003

01-12-2003 | Case Report

Rheumatoid meningitis: an autopsy report and review of the literature

Authors: Takashi Kato, Ken-ichi Hoshi, Yoshiki Sekijima, Masayuki Matsuda, Takao Hashimoto, Masako Otani, Akio Suzuki, Shu-ichi Ikeda

Published in: Clinical Rheumatology | Issue 6/2003

Login to get access

Abstract

We report the clinical and autopsy findings of a 71-year-old Japanese woman with rheumatoid meningitis. This patient developed subacute meningitis during an inactive stage of rheumatoid arthritis (RA), and despite intensive examinations no causative agents or underlying disease could be identified except for RA. Based on persistent hypocomplementaemia and increased serum levels of immune complexes she was suspected of having vasculitis, and was treated with intravenous methylprednisolone (1000 mg/day for 3 days) followed by oral prednisolone. Soon after beginning treatment with corticosteroid her symptoms improved, in parallel with a decrease in cell counts and interleukin-6 in the cerebrospinal fluid. During tapering of oral prednisolone she died of a subarachnoid haemorrhage which was ascribed to a relapse of the meningitis. Autopsy demonstrated infiltration of mononuclear cells, including plasma cells, in the leptomeninges, mainly around small vessels, leading to a definite diagnosis of rheumatoid meningitis. When RA patients manifest intractable meningitis with a subacute course, this disease is important as a possible diagnosis even if the arthritis is inactive, and intensive treatment, including corticosteroid and immunosuppressants, should be positively considered as a therapeutic option as soon as possible because of the poor prognosis.
Literature
1.
go back to reference Bathon JM, Moreland LW, DiBartolomeo AG (1989) Inflammatory central nervous system involvement in rheumatoid arthritis. Semin Arthritis Rheum 18:258–266PubMed Bathon JM, Moreland LW, DiBartolomeo AG (1989) Inflammatory central nervous system involvement in rheumatoid arthritis. Semin Arthritis Rheum 18:258–266PubMed
2.
go back to reference Yucel AE, Kart H, Aydin P et al. (2001) Pachymeningitis and optic neuritis in rheumatoid arthritis: successful treatment with cyclophosphamide. Clin Rheumatol 20:136–139PubMed Yucel AE, Kart H, Aydin P et al. (2001) Pachymeningitis and optic neuritis in rheumatoid arthritis: successful treatment with cyclophosphamide. Clin Rheumatol 20:136–139PubMed
3.
go back to reference Arnett FC, Edworthy SM, Bloch DA et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMed Arnett FC, Edworthy SM, Bloch DA et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMed
4.
go back to reference Steinbrocker O, Traeger CH, Batterman RC (1949) Therapeutic criteria in rheumatoid arthritis. JAMA 140:659–662 Steinbrocker O, Traeger CH, Batterman RC (1949) Therapeutic criteria in rheumatoid arthritis. JAMA 140:659–662
5.
go back to reference Hochberg MC, Chang RW, Dwosh I, Lindsey S, Pincus T, Wolfe F (1992) The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum 35:498–502 Hochberg MC, Chang RW, Dwosh I, Lindsey S, Pincus T, Wolfe F (1992) The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum 35:498–502
6.
go back to reference Scott DG, Bacon PA, Allen C, Elson CJ, Wallington T (1981) IgG rheumatoid factor, complement and immune complexes in rheumatoid synovitis and vasculitis: comparative and serial studies during cytotoxic therapy. Clin Exp Immunol 43:54–63PubMed Scott DG, Bacon PA, Allen C, Elson CJ, Wallington T (1981) IgG rheumatoid factor, complement and immune complexes in rheumatoid synovitis and vasculitis: comparative and serial studies during cytotoxic therapy. Clin Exp Immunol 43:54–63PubMed
7.
go back to reference Markenson JA, McDougal JS, Tsairis P, Lockshin MD, Christian CL (1979) Rheumatoid meningitis: a localized immune process. Ann Intern Med 90: 786–789PubMed Markenson JA, McDougal JS, Tsairis P, Lockshin MD, Christian CL (1979) Rheumatoid meningitis: a localized immune process. Ann Intern Med 90: 786–789PubMed
8.
go back to reference Choy EH, Panayi GS (2001) Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 344:907–916PubMed Choy EH, Panayi GS (2001) Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 344:907–916PubMed
9.
go back to reference Maher FA (1954) Dural nodules in rheumatoid arthritis. Arch Pathol 58:354–359 Maher FA (1954) Dural nodules in rheumatoid arthritis. Arch Pathol 58:354–359
10.
go back to reference Ellman P, Cudkowicz L, Elwood JS (1954) Widespread serous membrane involvement by rheumatoid nodules. J Clin Pathol 7:239–244PubMed Ellman P, Cudkowicz L, Elwood JS (1954) Widespread serous membrane involvement by rheumatoid nodules. J Clin Pathol 7:239–244PubMed
11.
go back to reference Steiner JW, Gelbloom AJ (1959) Intracranial manifestations in two cases of systemic rheumatoid disease. Arthritis Rheum 2:537–545 Steiner JW, Gelbloom AJ (1959) Intracranial manifestations in two cases of systemic rheumatoid disease. Arthritis Rheum 2:537–545
12.
go back to reference Johnson RL, Smyth CJ, Holt GW, Lubchenco A, Valentine E (1959) Steroid therapy and vascular lesions in rheumatoid arthritis. Arthritis Rheum 2:224–249 Johnson RL, Smyth CJ, Holt GW, Lubchenco A, Valentine E (1959) Steroid therapy and vascular lesions in rheumatoid arthritis. Arthritis Rheum 2:224–249
13.
go back to reference Contin JU, Oka M (1966) Unusual cardiac, pulmonary and meningeal involvement in rheumatoid arthritis. Dis Chest 49:552–555PubMed Contin JU, Oka M (1966) Unusual cardiac, pulmonary and meningeal involvement in rheumatoid arthritis. Dis Chest 49:552–555PubMed
14.
go back to reference Ouyang R, Mitchell DM, Rozdilsky B (1967) Central nervous system involvement in rheumatoid disease. Report of a case. Neurology 17:1099–1105PubMed Ouyang R, Mitchell DM, Rozdilsky B (1967) Central nervous system involvement in rheumatoid disease. Report of a case. Neurology 17:1099–1105PubMed
15.
go back to reference Ramos M, Mandybur TI (1975) Cerebral vasculitis in rheumatoid arthritis. Arch Neurol 32:271–275PubMed Ramos M, Mandybur TI (1975) Cerebral vasculitis in rheumatoid arthritis. Arch Neurol 32:271–275PubMed
16.
go back to reference Sunter JP (1977) Rheumatoid disease with involvement of the leptomeninges presenting as symptomatic epilepsy. Beitr Pathol 161:194–202PubMed Sunter JP (1977) Rheumatoid disease with involvement of the leptomeninges presenting as symptomatic epilepsy. Beitr Pathol 161:194–202PubMed
17.
go back to reference Watson P, Fekete J, Deck J (1977) Central nervous system vasculitis in rheumatoid arthritis. Can J Neurol Sci 4:269–272PubMed Watson P, Fekete J, Deck J (1977) Central nervous system vasculitis in rheumatoid arthritis. Can J Neurol Sci 4:269–272PubMed
18.
go back to reference Schachenmayr W, Friede RL (1978) Dural involvement in rheumatoid arthritis. Acta Neuropathol (Berl) 42:65–66 Schachenmayr W, Friede RL (1978) Dural involvement in rheumatoid arthritis. Acta Neuropathol (Berl) 42:65–66
19.
go back to reference Kim RC (1980) Rheumatoid disease with encephalopathy. Ann Neurol 7:86–91PubMed Kim RC (1980) Rheumatoid disease with encephalopathy. Ann Neurol 7:86–91PubMed
20.
go back to reference Kim RC, Collins GH, Parisi JE (1982) Rheumatoid nodule formation within the choroid plexus. Report of a second case. Arch Pathol Lab Med 106:83–84PubMed Kim RC, Collins GH, Parisi JE (1982) Rheumatoid nodule formation within the choroid plexus. Report of a second case. Arch Pathol Lab Med 106:83–84PubMed
21.
go back to reference Rodnan GP (1984) Clinical pathological conference. J Rheumatol 11:855–861PubMed Rodnan GP (1984) Clinical pathological conference. J Rheumatol 11:855–861PubMed
22.
go back to reference Spurlock RG, Richman AV (1983) Rheumatoid meningitis. A case report and review of the literature. Arch Pathol Lab Med 107:129–131PubMed Spurlock RG, Richman AV (1983) Rheumatoid meningitis. A case report and review of the literature. Arch Pathol Lab Med 107:129–131PubMed
23.
go back to reference Jackson CG, Chess RL, Ward JR (1984) A case of rheumatoid nodule formation within the central nervous system and review of the literature. J Rheumatol 11:237–240PubMed Jackson CG, Chess RL, Ward JR (1984) A case of rheumatoid nodule formation within the central nervous system and review of the literature. J Rheumatol 11:237–240PubMed
24.
go back to reference Hino H, Aoto K (1995) Rheumatoid meningitis. Shinkeinaika 42:70–72 [in Japanese] Hino H, Aoto K (1995) Rheumatoid meningitis. Shinkeinaika 42:70–72 [in Japanese]
25.
go back to reference Nishikawa M, Sakamoto H, Kishi H et al. (1996) A case of rheumatoid factor-positive pachymeningitis. No To Shinkei 48:735–739 [in Japanese with English abstract]PubMed Nishikawa M, Sakamoto H, Kishi H et al. (1996) A case of rheumatoid factor-positive pachymeningitis. No To Shinkei 48:735–739 [in Japanese with English abstract]PubMed
26.
go back to reference Otsuka M, Fujiwara T, Kuwata Y, Yamada S, Ueki A (1997) A case of rheumatoid pachymenigitis. Rinsho Shinkeigaku 37:834–840 [in Japanese with English abstract]PubMed Otsuka M, Fujiwara T, Kuwata Y, Yamada S, Ueki A (1997) A case of rheumatoid pachymenigitis. Rinsho Shinkeigaku 37:834–840 [in Japanese with English abstract]PubMed
Metadata
Title
Rheumatoid meningitis: an autopsy report and review of the literature
Authors
Takashi Kato
Ken-ichi Hoshi
Yoshiki Sekijima
Masayuki Matsuda
Takao Hashimoto
Masako Otani
Akio Suzuki
Shu-ichi Ikeda
Publication date
01-12-2003
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 6/2003
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-003-0788-0

Other articles of this Issue 6/2003

Clinical Rheumatology 6/2003 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine